147 related articles for article (PubMed ID: 35415903)
1. Association of polymorphisms in genes encoding prothrombotic and cardiovascular risk factors with disease severity in COVID-19 patients: A pilot study.
Lapić I; Radić Antolic M; Horvat I; Premužić V; Palić J; Rogić D; Zadro R
J Med Virol; 2022 Aug; 94(8):3669-3675. PubMed ID: 35415903
[TBL] [Abstract][Full Text] [Related]
2. Genetic cardiovascular risk factors and age-related macular degeneration.
Haas P; Aggermann T; Steindl K; Krugluger W; Pühringer H; Oberkanins C; Frantal S; Binder S
Acta Ophthalmol; 2011 Jun; 89(4):335-8. PubMed ID: 19860767
[TBL] [Abstract][Full Text] [Related]
3. The effects of genetic polymorphisms and diabetes mellitus on the development of peripheral artery disease.
Yalım Z; Tutgun Onrat S; Alan S; Aldemir M; Avşar A; Doğan İ; Onrat E
Turk Kardiyol Dern Ars; 2020 Jul; 48(5):484-493. PubMed ID: 32633259
[TBL] [Abstract][Full Text] [Related]
4. Combined presence of coagulation factor XIII V34L and plasminogen activator inhibitor 1 4G/5G gene polymorphisms significantly contribute to recurrent pregnancy loss in Serbian population.
Joksic I; Mikovic Z; Filimonovic D; Munjas J; Karadzov ON; Egic A; Joksic G
J Med Biochem; 2020 Jan; 39(2):199-207. PubMed ID: 33033453
[TBL] [Abstract][Full Text] [Related]
5. Association of Polymorphisms in Coagulation Factor Genes and Enzymes of Homocysteine Metabolism With Arterial Ischemic Stroke in Children.
Coen Herak D; Lenicek Krleza J; Radic Antolic M; Horvat I; Djuranovic V; Zrinski Topic R; Zadro R
Clin Appl Thromb Hemost; 2017 Nov; 23(8):1042-1051. PubMed ID: 28301901
[TBL] [Abstract][Full Text] [Related]
6. Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism.
Fiorentino G; Benincasa G; Coppola A; Franzese M; Annunziata A; Affinito O; Viglietti M; Napoli C
J Thromb Thrombolysis; 2023 Jan; 55(1):51-59. PubMed ID: 36371754
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey.
Oztuzcu S; Ergun S; Ulaşlı M; Nacarkahya G; Iğci YZ; Iğci M; Bayraktar R; Tamer A; Çakmak EA; Arslan A
Mol Biol Rep; 2014 Jun; 41(6):3671-6. PubMed ID: 24532105
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of myocardial infarction polymorphisms in Afyonkarahisar, Western Turkey.
Onrat ST; Akci O; Söylemez Z; Onrat E; Avşar A
Mol Biol Rep; 2012 Sep; 39(9):9257-64. PubMed ID: 22752805
[TBL] [Abstract][Full Text] [Related]
10. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?
Gokalp D; Tuzcu A; Bahceci M; Ayyildiz O; Yurt M; Celik Y; Alpagat G
Pituitary; 2011 Jun; 14(2):168-73. PubMed ID: 21107737
[TBL] [Abstract][Full Text] [Related]
11. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.
Coulam CB; Wallis D; Weinstein J; DasGupta DS; Jeyendran RS
Am J Reprod Immunol; 2008 Nov; 60(5):426-31. PubMed ID: 18803625
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
13. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
[TBL] [Abstract][Full Text] [Related]
14. [Association of polymorphic variants of hemostatic system genes with the course of COVID-19].
Nikolaeva LI; Stuchinskaya MD; Dedova AV; Nadezhda SG; Khlopova IN; Kruzhkova IS; Merkulova LN; Kisteneva LB; Kolobukhina LV; Mukasheva EA; Krasnoslobodtsev KG; Trushakova SV; Krepkaya AS; Kuprianov VV; Nikitenko NA; Khadorich EA; Burmistrov EM; Tyurin IN; Antipyat NA; Burtseva EI
Vopr Virusol; 2023 Nov; 68(5):445-453. PubMed ID: 38156578
[TBL] [Abstract][Full Text] [Related]
15. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
Velickovic J; Jelicic M; Stojkovic O
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):103-107. PubMed ID: 33555692
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study.
Ranellou K; Paraskeva A; Kyriazopoulos P; Batistatou A; Evangelou A; El-Aly M; Zis P; Tavernarakis A; Charalabopoulos K
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):430-5. PubMed ID: 25699610
[TBL] [Abstract][Full Text] [Related]
17. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
[TBL] [Abstract][Full Text] [Related]
18. Prothrombotic genetic risk factors in young survivors of myocardial infarction.
Ardissino D; Mannucci PM; Merlini PA; Duca F; Fetiveau R; Tagliabue L; Tubaro M; Galvani M; Ottani F; Ferrario M; Corral J; Margaglione M
Blood; 1999 Jul; 94(1):46-51. PubMed ID: 10381497
[TBL] [Abstract][Full Text] [Related]
19. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
20. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N
Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
